NCT05217082View on ClinicalTrials.gov

A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2022

Conditions
Multiple Myeloma
Trial Locations (1)

27560

Local Institution - 0001, Morrisville

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05217082 - A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure | Biotech Hunter | Biotech Hunter